![Doug Bolster, PhD, vice president of scientific and medical affairs at OLIPOP, discussed how formulation science and clinical research are shaping the next generation of functional beverages designed to address dietary fiber gaps and support gut health. "As we continue to innovate in this space, we want to continue to engage different taxa, [and] we want to look at different endpoints."](https://www.nutraingredients.com/resizer/v2/Y7G6CLZYVZAJDB7FO2ZT46X5XY.jpg?auth=7e430764455b80a1babc7d9fc84f0d7618debd6b1ec5e863a920e7ac14a7227d&height=281)
More than 300 delegates gathered in Vancouver earlier this month for Probiota Americas 2026, where discussions reflected both the rapid pace of microbiome research and the challenges of translating that science into successful products.
Hosted by NutraIngredients, the three-day conference brought together researchers, ingredient suppliers, manufacturers, brands and regulators to explore the latest developments across probiotics, prebiotics, postbiotics and the wider microbiome space.
Browse our photo gallery for highlights from this year’s event.
Science moves beyond the gut
The program reflected how much the microbiome category has expanded in recent years. Sessions explored emerging research on healthspan and longevity, women’s health, bioremediation of environmental pollutants, metabolic health, companion animals, and bacteriophages, underscoring the microbiome’s growing relevance across multiple areas of health.
Commercial discussions were just as prominent. Speakers examined opportunities in Asia, the rise of AI-powered personalization, the growing interest in functional beverages and the continued evolution of weight management and GLP-1 support.
Across those conversations, the focus wasn’t simply on identifying the next opportunity, but on bringing science-backed innovations to market in ways that resonate with consumers.
Evidence takes center stage
Whether the discussion centered on regulation, product development or consumer trust, one topic surfaced repeatedly: evidence.
Speakers emphasized the need for stronger clinical validation, strain-specific research and claims that can withstand increasing scrutiny from regulators, healthcare practitioners and consumers alike.
During a fireside chat on the gut-hormone axis, Daily Nouri founder and CEO Caroline Carralero observed that consumers are becoming more discerning, describing women as “reading the underlying papers, listening to researchers on podcasts, and asking pointed questions about strain identity, viable CFU at end of shelf life, and outcome data.”
That emphasis on scientific rigor was reflected throughout the conference, from the Probiota Pioneers competition and Scientific Frontiers presentations to the many networking opportunities designed to connect researchers with industry.
A conversation that continues
The final session invited audience members to weigh in on some of the issues likely to shape the microbiome sector over the next year, including precision fermentation, claim substantiation and other emerging trends. Judging by the lively discussion, there was no shortage of opinions about where the industry is headed.
Browse the gallery for a look back at some of the conversations, connections and standout moments from Probiota Americas 2026.
